ERYTECH Announces Resubmission of European Marketing Authorization Application for GRASPA in Acute Lymphoblastic Leukemia

October 10, 2017

LYON, France--(BUSINESS WIRE)--Oct. 10, 2017-- Regulatory News: ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood ce

Read More

ERYTECH Files Registration Statement for Proposed Initial Public Offering in the United States

October 6, 2017

LYON, France--(BUSINESS WIRE)--Oct. 6, 2017-- ERYTECH Pharma (Paris:ERYP) (ADR:EYRYY) (Euronext Paris: ERYP) (“ERYTECH”), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red

Read More